ArticlePharmacoEconomics2019

Cost-Effectiveness Analysis of Non-Statin Lipid-Modifying Agents for Secondary Cardiovascular Disease Prevention Among Statin-Treated Patients in Thailand.

Khachen Kongpakwattana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.